Literature DB >> 2864972

Interactions of beta-adrenoceptor antagonists and thyroid hormones in the control of heart rate in the dog.

M C Allely, A Ungar.   

Abstract

Propranolol, sotalol and nadolol have been infused into conscious dogs, and doses at which the three drugs are equipotent as beta-adrenoceptor antagonists determined. In euthyroid dogs, sotalol was more effective at lowering heart-rate than an equivalent dose of propranolol, while an equivalent dose of nadolol was without effect. Hyperthyroidism potentiated the lowering of heart-rate by sotalol, but inhibited that by propranolol. The effect of sotalol on heart-rate was correlated with its prolongation of the Q-T interval of the ECG. That of propranolol was correlated with its prolongation of the P-R interval. Nadolol did not affect P-R interval or Q-T interval except at relatively high dosage. We conclude that the tachycardia of hyperthyroidism is not affected by blockade of beta-adrenoceptors and therefore that it is not mediated by adrenergic mechanisms. The effectiveness of propranolol and sotalol in lowering heart-rate must be due to actions peculiar to those drugs, and not to beta-adrenoceptor antagonism.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2864972      PMCID: PMC1916683          DOI: 10.1111/j.1476-5381.1985.tb08908.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  9 in total

1.  Pharmacology of nadolol (SQ 11725), a beta-adrenergic antagonist lacking direct myocardial depression.

Authors:  R J Lee; D B Evans; S H Baky; R J Laffan
Journal:  Eur J Pharmacol       Date:  1975 Sep-Oct       Impact factor: 4.432

2.  Direct myocardial depressant effects of several beta-adrenergic blocking agents in the unanesthetized atherosclerotic rabbit.

Authors:  R J Lee; D D Dickerson; I E Fulmor; M E Goldberg
Journal:  Proc Soc Exp Biol Med       Date:  1978-06

3.  Controlled trial of propranolol in thyrotoxicosis.

Authors:  R G Shanks; D R Hadden; D C Lowe; D G McDevitt; D A Montgomery
Journal:  Lancet       Date:  1969-05-17       Impact factor: 79.321

4.  Class III action of beta-blocking agents.

Authors:  P Taggart; R Donaldson; J Abed; F Nashat
Journal:  Cardiovasc Res       Date:  1984-11       Impact factor: 10.787

5.  Quantitative changes in beta-adrenergic responses of isolated atria from hyper- and hypothyroid rats.

Authors:  H P Rub; H Thommen; H Porzig
Journal:  Experientia       Date:  1981-04-15

6.  New perspectives on thyroid hormone, catecholamines, and the heart.

Authors:  I Klein; G S Levey
Journal:  Am J Med       Date:  1984-02       Impact factor: 4.965

7.  QT and action potential duration.

Authors:  E M Vaughan Williams
Journal:  Br Heart J       Date:  1982-06

8.  D-propranolol and DL-propranolol both decrease conversion of L-thyroxine to L-triiodothyronine.

Authors:  P Heyma; R G Larkins; L Higginbotham; K W Ng
Journal:  Br Med J       Date:  1980-07-05

9.  Cardiovascular responses in hyperthyroidism before and during beta-adrenoceptor blockade: evidence against adrenergic hypersensitivity.

Authors:  J C Forfar; J Stewart; A Sawers; A D Toft
Journal:  Clin Endocrinol (Oxf)       Date:  1982-05       Impact factor: 3.478

  9 in total
  2 in total

Review 1.  The management of acute poisoning due to beta-adrenoceptor antagonists.

Authors:  J A Critchley; A Ungar
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Jan-Feb

2.  Propranolol and thyroxine-induced hypertrophic rabbit hearts: effect on heart size and regional O2 supply/consumption variables.

Authors:  G J Grover; J M Houghton; H R Weiss
Journal:  Basic Res Cardiol       Date:  1988 May-Jun       Impact factor: 17.165

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.